On the public citation graph

Persistence of nevirapine-resistant HIV-1 in women after single-dose nevirapine therapy for prevention of maternal-to-fetal HIV-1 transmission

https://doi.org/10.1073/pnas.0602033103

0 signed · 179 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.292.2.202openalex-snapshot

Nevirapine and Zidovudine at Birth to Reduce Perinatal Transmission of HIV in an African Setting

inferredcites →https://doi.org/10.1006/meth.1996.0122openalex-snapshot

Comparison of a Chemically Mediated and an Immunologically Mediated Demyelinating Lesion Model

inferredcites →https://doi.org/10.1006/viro.2001.0920openalex-snapshot

Impact of Clinical Reverse Transcriptase Sequences on the Replication Capacity of HIV-1 Drug-Resistant Mutants

inferredcites →https://doi.org/10.1007/978-1-4757-9209-6_26openalex-snapshot

Clinical Experience with Non-Nucleoside Reverse Transcriptase Inhibitors: L-697,661 and Nevirapine

inferredcites →https://doi.org/10.1016/s0076-6879(96)75026-7openalex-snapshot

[24] Development of nonnucleoside HIV reverse transcriptase inhibitors

inferredcites →https://doi.org/10.1016/s0140-6736(02)08909-2openalex-snapshot

HIV-1/AIDS and maternal and child health in Africa

inferredcites →https://doi.org/10.1016/s0140-6736(03)14341-3openalex-snapshot

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial

inferredcites →https://doi.org/10.1016/s0140-6736(03)14907-0openalex-snapshot

Nevirapine to prevent mother-to-child transmission of HIV-1 among women of unknown serostatus

inferredcites →https://doi.org/10.1016/s0140-6736(99)80008-7openalex-snapshot

Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial

inferredcites →https://doi.org/10.1056/nejm199411033311801openalex-snapshot

Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine Treatment

inferredcites →https://doi.org/10.1056/nejmoa033500openalex-snapshot

Single-Dose Perinatal Nevirapine plus Standard Zidovudine to Prevent Mother-to-Child Transmission of HIV-1 in Thailand

inferredcites →https://doi.org/10.1056/nejmoa035103openalex-snapshot

Structured Treatment Interruption in Patients with Multidrug-Resistant Human Immunodeficiency Virus

inferredcites →https://doi.org/10.1056/nejmoa041305openalex-snapshot

Intrapartum Exposure to Nevirapine and Subsequent Maternal Responses to Nevirapine-Based Antiretroviral Therapy

inferredcites →https://doi.org/10.1086/318530openalex-snapshot

Perinatal Transmission of Human Immunodeficiency Virus Type 1 by Pregnant Women with RNA Virus Loads <1000 Copies/mL

inferredcites →https://doi.org/10.1086/430741openalex-snapshot

Emergence of Drug‐Resistant HIV‐1 after Intrapartum Administration of Single‐Dose Nevirapine Is Substantially Underestimated

inferredcites →https://doi.org/10.1086/430742openalex-snapshot

Sensitive Drug‐Resistance Assays Reveal Long‐Term Persistence of HIV‐1 Variants with the K103N Nevirapine (NVP) Resistance Mutation in Some Women and Infants after the Administration of Single‐Dose NVP: HIVNET 012

inferredcites →https://doi.org/10.1086/515641openalex-snapshot

Pharmacokinetics of Nevirapine in Human Immunodeficiency Virus Type 1-Infected Pregnant Women and Their Neonates

inferredcites →https://doi.org/10.1089/088922202753472801openalex-snapshot

Underestimation of HIV Type 1 Drug Resistance Mutations: Results from the ENVA-2 Genotyping Proficiency Program

inferredcites →https://doi.org/10.1089/aid.1998.14.869openalex-snapshot

Comparative Performance of High-Density Oligonucleotide Sequencing and Dideoxynucleotide Sequencing of HIV Type 1 pol from Clinical Samples

inferredcites →https://doi.org/10.1097/00002030-199903110-00006openalex-snapshot

A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006)

inferredcites →https://doi.org/10.1097/00002030-200104130-00012openalex-snapshot

HIV-infected pregnant women and vertical transmission in Europe since 1986

inferredcites →https://doi.org/10.1097/00002030-200110190-00006openalex-snapshot

Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012)

inferredcites →https://doi.org/10.1097/00002030-200201040-00001openalex-snapshot

Visiting Solomon: AIDS in Ethiopia

inferredcites →https://doi.org/10.1097/00002030-200306130-00012openalex-snapshot

Prevention of mother-to-child transmission of HIV in Africa: successes and challenges in scaling-up a nevirapine-based program in Lusaka, Zambia

inferredcites →https://doi.org/10.1097/00006254-199504000-00002openalex-snapshot

Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus 1 with Zidovudine Treatment

inferredcites →https://doi.org/10.1097/00006454-200207000-00012openalex-snapshot

Trends in interventions to reduce perinatal human immunodeficiency virus type 1 transmission in North Carolina

inferredcites →https://doi.org/10.1097/00042560-200103011-00004openalex-snapshot

Nonnucleoside Reverse Transcriptase Inhibitor Resistance

inferredcites →https://doi.org/10.1097/00126334-200103011-00004openalex-snapshot

Nonnucleoside Reverse Transcriptase Inhibitor Resistance

inferredcites →https://doi.org/10.1097/00126334-200501010-00007openalex-snapshot

Detection of Minority Populations of HIV-1 Expressing the K103N Resistance Mutation in Patients Failing Nevirapine

inferredcites →https://doi.org/10.1097/01.aids.0000216370.69066.7fopenalex-snapshot

Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy

inferredcites →https://doi.org/10.1128/jcm.43.1.406-413.2005openalex-snapshot

Multiple, Linked Human Immunodeficiency Virus Type 1 Drug Resistance Mutations in Treatment-Experienced Patients Are Missed by Standard Genotype Analysis

inferredcites →https://doi.org/10.1128/jvi.68.3.1660-1666.1994openalex-snapshot

Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy

inferredcites →https://doi.org/10.1128/jvi.70.11.7894-7899.1996openalex-snapshot

Nevirapine-resistant human immunodeficiency virus: kinetics of replication and estimated prevalence in untreated patients

inferredcites →https://doi.org/10.2165/00003495-200464050-00002openalex-snapshot

Treatment of HIV Infection in Pregnant Women

inferredcites →https://doi.org/10.7326/0003-4819-124-12-199606150-00001openalex-snapshot

Nevirapine, Zidovudine, and Didanosine Compared with Zidovudine and Didanosine in Patients with HIV-1 Infection

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2105/ajph.2006.093526_3openalex-extracted

inferred← citeshttps://doi.org/10.1002/jmv.21628openalex-snapshot

Application of an allele‐specific PCR to clinical HIV genotyping samples detects additional K103N mutations in both therapy naïve and experienced patients

inferred← citeshttps://doi.org/10.1002/rmv.543openalex-snapshot

Biological mechanisms of vertical human immunodeficiency virus (HIV‐1) transmission

inferred← citeshttps://doi.org/10.1007/82_2015_440openalex-snapshot

HIV Therapy—The State of ART

inferred← citeshttps://doi.org/10.1007/978-1-4614-7291-9_6openalex-snapshot

Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs)

inferred← citeshttps://doi.org/10.1007/978-1-4939-0667-3_27-1openalex-snapshot

HIV Drug Resistance in Mothers and Infants Following Use of Antiretrovirals to Prevent Mother-to-Child Transmission

inferred← citeshttps://doi.org/10.1007/978-1-4939-0694-9_27openalex-snapshot

HIV Drug Resistance in Mothers and Infants Following Use of Antiretrovirals to Prevent Mother-to-Child Transmission

inferred← citeshttps://doi.org/10.1007/b135974_26openalex-snapshot

Clinical Implications of Reverse Transcriptase Inhibitor Resistance

inferred← citeshttps://doi.org/10.1007/s15010-026-02968-8openalex-snapshot

Integrated analysis of HIV-1 drug resistance across reverse transcriptase, protease and integrase in india: gene-region-corrected prevalence and threshold-specific scoring from public sequence data

inferred← citeshttps://doi.org/10.1016/b978-0-12-374235-3.00017-0openalex-snapshot

Preventing mother-to-child transmission of HIV

inferred← citeshttps://doi.org/10.1016/b978-0-443-06839-3.00128-4openalex-snapshot

Antiretroviral Therapy for Human Immunodeficiency Virus Infection

inferred← citeshttps://doi.org/10.1016/b978-1-4160-2882-6.50050-2openalex-snapshot

Antiretroviral Therapy of Drug-resistant HIV

inferred← citeshttps://doi.org/10.1016/b978-1-4160-6400-8.00021-3openalex-snapshot

Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome in the Infant

inferred← citeshttps://doi.org/10.1016/b978-1-4557-4801-3.00130-2openalex-snapshot

Antiretroviral Therapy for Human Immunodeficiency Virus Infection

inferred← citeshttps://doi.org/10.1016/j.ajog.2007.02.031openalex-snapshot

Use of single-dose nevirapine for the prevention of mother-to-child transmission of HIV-1: does development of resistance matter?

inferred← citeshttps://doi.org/10.1016/j.ajog.2007.03.001openalex-snapshot

International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update

inferred← citeshttps://doi.org/10.1016/j.antiviral.2009.09.015openalex-snapshot

Clinical management of HIV-1 resistance

inferred← citeshttps://doi.org/10.1016/j.contraception.2010.10.002openalex-snapshot

Trends and correlates of hormonal contraceptive use among HIV-infected women in Rakai, Uganda, 1994–2006

inferred← citeshttps://doi.org/10.1016/j.jcv.2010.03.017openalex-snapshot

Minor resistant variants in nevirapine-exposed infants may predict virologic failure on nevirapine-containing ART

inferred← citeshttps://doi.org/10.1016/j.jviromet.2008.01.005openalex-snapshot

Improvement in allele-specific PCR assay with the use of polymorphism-specific primers for the analysis of minor variant drug resistance in HIV-1 subtype C

inferred← citeshttps://doi.org/10.1016/j.jviromet.2009.11.025openalex-snapshot

Optimization of allele-specific PCR using patient-specific HIV consensus sequences for primer design

inferred← citeshttps://doi.org/10.1016/j.jviromet.2014.07.010openalex-snapshot

Concordance between allele-specific PCR and ultra-deep pyrosequencing for the detection of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutations

inferred← citeshttps://doi.org/10.1016/s0140-6736(06)69157-5openalex-snapshot

HIV/AIDS epidemiology, pathogenesis, prevention, and treatment

inferred← citeshttps://doi.org/10.1016/s0213-005x(13)70112-5openalex-snapshot

Detección de mutaciones de resistencia en ADN proviral en infección por VIH-1

inferred← citeshttps://doi.org/10.1056/ac200606140000006openalex-snapshot

Resistance Mutations Persist After Single-Dose Nevirapine

inferred← citeshttps://doi.org/10.1056/nejmoa062876openalex-snapshot

Response to Antiretroviral Therapy after a Single, Peripartum Dose of Nevirapine

inferred← citeshttps://doi.org/10.1056/nejmoa0906626openalex-snapshot

Antiretroviral Therapies in Women after Single-Dose Nevirapine Exposure

inferred← citeshttps://doi.org/10.1073/pnas.1105688108openalex-snapshot

Role of low-frequency HIV-1 variants in failure of nevirapine-containing antiviral therapy in women previously exposed to single-dose nevirapine

inferred← citeshttps://doi.org/10.1073/pnas.1110064108openalex-snapshot

Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID

inferred← citeshttps://doi.org/10.1080/15284336.2017.1411419openalex-snapshot

Implementation of a prospective pregnancy registry for antiretroviral based HIV prevention trials

inferred← citeshttps://doi.org/10.1086/587657openalex-snapshot

Plasma Drug Concentrations and Virologic Evaluations after Stopping Treatment with Nonnucleoside Reverse‐Transcriptase Inhibitors in HIV Type 1–Infected Children

inferred← citeshttps://doi.org/10.1086/589867openalex-snapshot

Detection of Nonnucleoside Reverse‐Transcriptase Inhibitor–Resistant HIV‐1 after Discontinuation of Virologically Suppressive Antiretroviral Therapy

inferred← citeshttps://doi.org/10.1086/590160openalex-snapshot

Nevirapine Resistance in Women and Infants after First versus Repeated Use of Single‐Dose Nevirapine for Prevention of HIV‐1 Vertical Transmission

inferred← citeshttps://doi.org/10.1086/596486openalex-snapshot

Persistent Minority K103N Mutations among Women Exposed to Single‐Dose Nevirapine and Virologic Response to Nonnucleoside Reverse‐Transcriptase Inhibitor–Based Therapy

inferred← citeshttps://doi.org/10.1086/596489openalex-snapshot

Single‐Dose Nevirapine to Prevent Mother‐to‐Child Transmission of HIV Type 1: Balancing the Benefits and Risks

inferred← citeshttps://doi.org/10.1086/596737openalex-snapshot

Low-Abundance Drug-Resistant HIV-1 Variants: Finding Significance in an Era of Abundant Diagnostic and Therapeutic Options

inferred← citeshttps://doi.org/10.1086/597759openalex-snapshot

Identification of Nevirapine‐Resistant HIV‐1 in the Latent Reservoir after Single‐Dose Nevirapine to Prevent Mother‐to‐Child Transmission of HIV‐1

inferred← citeshttps://doi.org/10.1086/597760openalex-snapshot

Establishment of Drug‐Resistant HIV‐1 in Latent Reservoirs

inferred← citeshttps://doi.org/10.1086/599612openalex-snapshot

Antiretroviral Resistance Patterns and HIV‐1 Subtype in Mother‐Infant Pairs after the Administration of Combination Short‐Course Zidovudine plus Single‐Dose Nevirapine for the Prevention of Mother‐to‐Child Transmission of HIV

inferred← citeshttps://doi.org/10.1086/650542openalex-snapshot

Low Frequency Nonnucleoside Reverse‐Transcriptase Inhibitor–Resistant Variants Contribute to Failure of Efavirenz‐Containing Regimens in Treatment‐Experienced Patients

inferred← citeshttps://doi.org/10.1086/650543openalex-snapshot

Pre‐existing Minority Drug‐Resistant HIV‐1 Variants, Adherence, and Risk of Antiretroviral Treatment Failure

inferred← citeshttps://doi.org/10.1086/650545openalex-snapshot

When Do Minority Drug‐Resistant HIV‐1 Variants Have a Major Clinical Impact?

inferred← citeshttps://doi.org/10.1086/652148openalex-snapshot

Association between Detection of HIV‐1 DNA Resistance Mutations by a Sensitive Assay at Initiation of Antiretroviral Therapy and Virologic Failure

inferred← citeshttps://doi.org/10.1086/652151openalex-snapshot

Nevirapine Resistance by Timing of HIV Type 1 Infection in Infants Treated with Single‐Dose Nevirapine

inferred← citeshttps://doi.org/10.1086/655397openalex-snapshot

Minority Variants of Drug‐Resistant HIV

inferred← citeshttps://doi.org/10.1086/655655openalex-snapshot

Clinical Management of Acute HIV Infection: Best Practice Remains Unknown

inferred← citeshttps://doi.org/10.1089/aid.2007.0012openalex-snapshot

Characterization of HIV-1 Isolates from Antiretroviral Drug-Naive Children in Southern India

inferred← citeshttps://doi.org/10.1089/aid.2007.0045openalex-snapshot

Drug Resistance in Plasma and Breast Milk after Single-Dose Nevirapine in Subtype C HIV Type 1: Population and Clonal Sequence Analysis

inferred← citeshttps://doi.org/10.1089/aid.2007.0138openalex-snapshot

A Radiolabeled Oligonucleotide Ligation Assay Demonstrates the High Frequency of Nevirapine Resistance Mutations in HIV Type 1 Quasispecies of NVP-Treated and Untreated Mother–Infant Pairs from Uganda

inferred← citeshttps://doi.org/10.1089/aid.2007.0213openalex-snapshot

Study of the Genotypic Resistant Pattern in HIV-Infected Women and Children from Rural West Cameroon

inferred← citeshttps://doi.org/10.1089/aid.2007.0224openalex-snapshot

Comparison of LigAmp and an ASPCR Assay for Detection and Quantification of K103N-Containing HIV Variants

inferred← citeshttps://doi.org/10.1089/aid.2007.0255openalex-snapshot

Drug-Resistance Mutations Number and K70R or T215Y/F Substitutions Predict Treatment Resumption during Guided Treatment Interruptions

inferred← citeshttps://doi.org/10.1089/aid.2008.0109openalex-snapshot

Analysis of Nevirapine Resistance Mutations in Cloned HIV Type 1 Variants from HIV-Infected Ugandan Infants Using a Single-Step Amplification-Sequencing Method (AmpliSeq)

inferred← citeshttps://doi.org/10.1089/aid.2009.0082openalex-snapshot

Ultrasensitive Detection of Minor Drug-Resistant Variants for HIV After Nevirapine Exposure Using Allele-Specific PCR: Clinical Significance

inferred← citeshttps://doi.org/10.1089/aid.2010.0346openalex-snapshot

Slower Clearance of Nevirapine Resistant Virus in Infants Failing Extended Nevirapine Prophylaxis for Prevention of Mother-to-Child HIV Transmission

inferred← citeshttps://doi.org/10.1089/aid.2011.0284openalex-snapshot

Primary Drug Resistance in South Africa: Data from 10 Years of Surveys

inferred← citeshttps://doi.org/10.1093/acprof:oso/9780199225859.003.0005openalex-snapshot

HAART in HIV-infected children: one decade later

inferred← citeshttps://doi.org/10.1093/cid/ciq161openalex-snapshot

Induction Therapy with Protease-Inhibitors Modifies the Effect of Nevirapine Resistance on Virologic Response to Nevirapine-based HAART in Children

inferred← citeshttps://doi.org/10.1093/cid/cir798openalex-snapshot

A Comparison of 3 Regimens to Prevent Nevirapine Resistance Mutations in HIV-Infected Pregnant Women Receiving a Single Intrapartum Dose of Nevirapine

inferred← citeshttps://doi.org/10.1093/cid/cis1219openalex-snapshot

Greater Suppression of Nevirapine Resistance With 21- vs 7-Day Antiretroviral Regimens After Intrapartum Single-Dose Nevirapine for Prevention of Mother-to-Child Transmission of HIV

inferred← citeshttps://doi.org/10.1093/cid/cit125openalex-snapshot

Clinical Implications of HIV-1 Minority Variants

inferred← citeshttps://doi.org/10.1093/cid/ciy909openalex-snapshot

Clinical and Virologic Outcomes Following Initiation of Antiretroviral Therapy Among Seroconverters in the Microbicide Trials Network-020 Phase III Trial of the Dapivirine Vaginal Ring

inferred← citeshttps://doi.org/10.1093/infdis/jis282openalex-snapshot

Effects of Short-Course Zidovudine on the Selection of Nevirapine-Resistant HIV-1 in Women Taking Single-Dose Nevirapine

inferred← citeshttps://doi.org/10.1093/infdis/jit635openalex-snapshot

Low-Frequency Nevirapine (NVP)–Resistant HIV-1 Variants Are Not Associated With Failure of Antiretroviral Therapy in Women Without Prior Exposure to Single-Dose NVP

inferred← citeshttps://doi.org/10.1093/infdis/jiu233openalex-snapshot

HIV-1 Drug Resistance in the iPrEx Preexposure Prophylaxis Trial

inferred← citeshttps://doi.org/10.1093/infdis/jix413openalex-snapshot

Current Status of Point-of-Care Testing for Human Immunodeficiency Virus Drug Resistance

inferred← citeshttps://doi.org/10.1093/jac/dkn441openalex-snapshot

Persistence of nevirapine in breast milk and plasma of mothers and their children after single-dose administration

inferred← citeshttps://doi.org/10.1093/jac/dkp419openalex-snapshot

Low-abundance HIV species and their impact on mutational profiles in patients with virological failure on once-daily abacavir/lamivudine/zidovudine and tenofovir

inferred← citeshttps://doi.org/10.1093/jac/dkq139openalex-snapshot

Low-frequency HIV-1 drug resistance mutations can be clinically significant but must be interpreted with caution

inferred← citeshttps://doi.org/10.1097/coh.0b013e3282f50becopenalex-snapshot

Prevention of mother-to-child transmission, drug resistance, and implications for response to therapy

inferred← citeshttps://doi.org/10.1097/qad.0b013e3280b077b6openalex-snapshot

Treatment resistance after sequential interruption of a non-nucleoside reverse transcriptase inhibitor-based regimen

inferred← citeshttps://doi.org/10.1097/qad.0b013e32833609a2openalex-snapshot

Antiretroviral monotherapy: should we abandon the principles of successful antiretroviral therapy?

inferred← citeshttps://doi.org/10.1097/qad.0b013e3283492180openalex-snapshot

HIV-1 drug resistance at antiretroviral treatment initiation in children previously exposed to single-dose nevirapine

inferred← citeshttps://doi.org/10.1097/qai.0b013e31802b920eopenalex-snapshot

Selection and Persistence of Viral Resistance in HIV-Infected Children After Exposure to Single-Dose Nevirapine

inferred← citeshttps://doi.org/10.1097/qai.0b013e318050d652openalex-snapshot

Transmission Rates in Consecutive Pregnancies Exposed to Single-Dose Nevirapine in Soweto, South Africa and Abidjan, Côte d'Ivoire

inferred← citeshttps://doi.org/10.1097/qai.0b013e318074eb73openalex-snapshot

Prevalence of HIV-1 Drug Resistance in Treated Patients

inferred← citeshttps://doi.org/10.1097/qai.0b013e31814b97e4openalex-snapshot

Effectiveness of Repeat Single-Dose Nevirapine for Prevention of Mother-to-Child Transmission of HIV-1 in Repeat Pregnancies in Uganda

inferred← citeshttps://doi.org/10.1097/qai.0b013e31818d5dcfopenalex-snapshot

Development of Phenotypic HIV-1 Drug Resistance After Exposure to Single-Dose Nevirapine

inferred← citeshttps://doi.org/10.1097/qai.0b013e3181a9972copenalex-snapshot

Increased Detection of HIV-1 Drug Resistance at Time of Diagnosis by Testing Viral DNA With a Sensitive Assay

inferred← citeshttps://doi.org/10.1097/qai.0b013e3181aa8a22openalex-snapshot

Lower Risk of Resistance After Short-Course HAART Compared With Zidovudine/Single-Dose Nevirapine Used for Prevention of HIV-1 Mother-to-Child Transmission

inferred← citeshttps://doi.org/10.1097/qco.0b013e328013f421openalex-snapshot

Preexposure prophylaxis for HIV infection: itʼs not as easy as ABC

inferred← citeshttps://doi.org/10.1097/qco.0b013e32811ebfb0openalex-snapshot

Adverse events following immunization: perception and evidence

inferred← citeshttps://doi.org/10.1101/gr.6468307openalex-snapshot

Characterization of mutation spectra with ultra-deep pyrosequencing: Application to HIV-1 drug resistance

inferred← citeshttps://doi.org/10.1111/cbdd.12277openalex-snapshot

Discovery of Novel Inhibitors of HIV ‐1 Reverse Transcriptase Through Virtual Screening of Experimental and Theoretical Ensembles

inferred← citeshttps://doi.org/10.1111/j.1468-1293.2007.00529.xopenalex-snapshot

Detection of drug‐resistant HIV minorities in clinical specimens and therapy failure

inferred← citeshttps://doi.org/10.1111/j.1468-1293.2008.00636.xopenalex-snapshot

British HIV Association guidelines for the treatment of HIV‐1‐infected adults with antiretroviral therapy 2008

inferred← citeshttps://doi.org/10.1111/j.1468-1293.2011.00971.xopenalex-snapshot

B ritish HIV A ssociation guidelines for the routine investigation and monitoring of adult HIV ‐1‐infected individuals 2011

inferred← citeshttps://doi.org/10.1111/j.1471-0528.2009.02312.xopenalex-snapshot

Preventing mother‐to‐child transmission of HIV

inferred← citeshttps://doi.org/10.1128/9781555819217.ch46openalex-snapshot

Reverse Transcription of Retroviruses and LTR Retrotransposons

inferred← citeshttps://doi.org/10.1128/aac.00910-06openalex-snapshot

Impact of Nevirapine (NVP) Plasma Concentration on Selection of Resistant Virus in Mothers Who Received Single-Dose NVP To Prevent Perinatal Human Immunodeficiency Virus Type 1 Transmission and Persistence of Resistant Virus in Their Infected Children

inferred← citeshttps://doi.org/10.1128/aac.01672-08openalex-snapshot

Detection and Quantification of Minor Human Immunodeficiency Virus Type 1 Variants Harboring K103N and Y181C Resistance Mutations in Subtype A and D Isolates by Allele-Specific Real-Time PCR

inferred← citeshttps://doi.org/10.1128/jcm.01512-06openalex-snapshot

MultiCode-RTx Real-Time PCR System for Detection of Subpopulations of K65R Human Immunodeficiency Virus Type 1 Reverse Transcriptase Mutant Viruses in Clinical Samples

inferred← citeshttps://doi.org/10.1128/jcm.02652-12openalex-snapshot

Evaluation of a Benchtop HIV Ultradeep Pyrosequencing Drug Resistance Assay in the Clinical Laboratory

inferred← citeshttps://doi.org/10.1128/jvi.01010-10openalex-snapshot

Estimating Frequencies of Minority Nevirapine-Resistant Strains in Chronically HIV-1-Infected Individuals Naive to Nevirapine by Using Stochastic Simulations and a Mathematical Model

inferred← citeshttps://doi.org/10.1128/jvi.01301-07openalex-snapshot

Suppression of Viremia and Evolution of Human Immunodeficiency Virus Type 1 Drug Resistance in a Macaque Model for Antiretroviral Therapy

inferred← citeshttps://doi.org/10.1128/jvi.02389-10openalex-snapshot

Evolution of Drug-Resistant Viral Populations during Interruption of Antiretroviral Therapy

inferred← citeshttps://doi.org/10.1128/microbiolspec.mdna3-0027-2014openalex-snapshot

Reverse Transcription of Retroviruses and LTR Retrotransposons

inferred← citeshttps://doi.org/10.11588/heidok.00010109openalex-snapshot

Genetic diversity and phenotypic characterization of HIV-1 circulating recombinant forms (CRFs) among drug-naive and -exposed patients in Burkina Faso

inferred← citeshttps://doi.org/10.1159/000121607openalex-snapshot

The Relationship between Ventricular Repolarization Duration and RR Interval in Normal Subjects and Patients with Myocardial Infarction

inferred← citeshttps://doi.org/10.1159/000345935openalex-snapshot

Recent Advances in Research of HIV Infection: Implications of Viral and Host Genetics on Treatment and Prevention

inferred← citeshttps://doi.org/10.1177/09564624221076618openalex-snapshot

Epidemiological drivers of mother to child HIV transmission in West Bengal, India: A retrospective cohort study

inferred← citeshttps://doi.org/10.1177/135965350801300705openalex-snapshot

Variability in the Plasma Concentration of Efavirenz and Nevirapine is Associated with Genotypic Resistance after Treatment Interruption

inferred← citeshttps://doi.org/10.1177/135965350801302s09openalex-snapshot

Antiretroviral drug resistance surveillance among drug-naive HIV-1-infected individuals in Gauteng Province, South Africa in 2002 and 2004

inferred← citeshttps://doi.org/10.1177/23259582211009011openalex-snapshot

The Promise of Improved Adherence With Long-Acting Antiretroviral Therapy: What Are the Data?

inferred← citeshttps://doi.org/10.1186/1471-2334-8-172openalex-snapshot

Reuse of single-dose nevirapine in subsequent pregnancies for the prevention of mother-to-child HIV transmission in Lusaka, Zambia: A cohort study

inferred← citeshttps://doi.org/10.1186/1742-4690-10-88openalex-snapshot

Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in breast milk following single-dose nevirapine prophylaxis

inferred← citeshttps://doi.org/10.1186/s12889-019-6707-3openalex-snapshot

Incidence, prevalence and associated factors of mother-to-child transmission of HIV, among children exposed to maternal HIV, in Belgaum district, Karnataka, India

inferred← citeshttps://doi.org/10.1186/s12981-017-0161-zopenalex-snapshot

High level of HIV-1 drug resistance mutations in patients with unsuppressed viral loads in rural northern South Africa

inferred← citeshttps://doi.org/10.1201/b13787-265openalex-snapshot

Nevirapine

inferred← citeshttps://doi.org/10.1258/ijsa.2010.010229openalex-snapshot

Efavirenz-based combination antiretroviral therapy after peripartum single-dose nevirapine

inferred← citeshttps://doi.org/10.1258/td.2011.100458openalex-snapshot

Reduced HIV transmission at subsequent pregnancy in a resource-poor setting

inferred← citeshttps://doi.org/10.1371/journal.pgen.1004179openalex-snapshot

Fifteen Years Later: Hard and Soft Selection Sweeps Confirm a Large Population Number for HIV In Vivo

inferred← citeshttps://doi.org/10.1371/journal.pmed.1000172openalex-snapshot

Efficacy of Short-Course AZT Plus 3TC to Reduce Nevirapine Resistance in the Prevention of Mother-to-Child HIV Transmission: A Randomized Clinical Trial

inferred← citeshttps://doi.org/10.1371/journal.pone.0000638openalex-snapshot

Simple PCR Assays Improve the Sensitivity of HIV-1 Subtype B Drug Resistance Testing and Allow Linking of Resistance Mutations

inferred← citeshttps://doi.org/10.1371/journal.pone.0004096openalex-snapshot

Nevirapine Resistance and Breast-Milk HIV Transmission: Effects of Single and Extended-Dose Nevirapine Prophylaxis in Subtype C HIV-Infected Infants

inferred← citeshttps://doi.org/10.1371/journal.pone.0015476openalex-snapshot

DNA Suspension Arrays: Silencing Discrete Artifacts for High-Sensitivity Applications

inferred← citeshttps://doi.org/10.1371/journal.pone.0020357openalex-snapshot

Emergence and Persistence of Minor Drug-Resistant HIV-1 Variants in Ugandan Women after Nevirapine Single-Dose Prophylaxis

inferred← citeshttps://doi.org/10.1371/journal.pone.0021655openalex-snapshot

Minor HIV-1 Variants with the K103N Resistance Mutation during Intermittent Efavirenz-Containing Antiretroviral Therapy and Virological Failure

inferred← citeshttps://doi.org/10.1371/journal.pone.0032055openalex-snapshot

Emergence of Minor Drug-Resistant HIV-1 Variants after Triple Antiretroviral Prophylaxis for Prevention of Vertical HIV-1 Transmission

inferred← citeshttps://doi.org/10.1371/journal.pone.0070388openalex-snapshot

PCR-Induced Transitions Are the Major Source of Error in Cleaned Ultra-Deep Pyrosequencing Data

inferred← citeshttps://doi.org/10.1371/journal.pone.0135941openalex-snapshot

Longitudinal Detection and Persistence of Minority Drug-Resistant Populations and Their Effect on Salvage Therapy

inferred← citeshttps://doi.org/10.17615/17vm-5h90openalex-snapshot

Minority drug resistant variants of HIV-1 and response to early combination therapy

inferred← citeshttps://doi.org/10.2105/ajph.2006.093526openalex-snapshot

Rethinking Mandatory HIV Testing During Pregnancy in Areas With High HIV Prevalence Rates: Ethical and Policy Issues

inferred← citeshttps://doi.org/10.2174/1570162x11311020005openalex-snapshot

HIV Drug Resistance in Mothers and Infants Following Use of Antiretrovirals to Prevent Mother-to-Child Transmission

inferred← citeshttps://doi.org/10.2217/14622416.8.6.533openalex-snapshot

More Sensitive Assays for Better Drug Resistance Prediction?

inferred← citeshttps://doi.org/10.2217/14750708.4.6.797openalex-snapshot

Prophylactic regimens to prevent mother-to-child transmission of HIV and their effect on future therapy

inferred← citeshttps://doi.org/10.2217/17460794.2.3.293openalex-snapshot

Minor-Drug-Resistant HIV Populations and Treatment Failure

inferred← citeshttps://doi.org/10.2217/17469600.1.1.23openalex-snapshot

Nevirapine Prophylaxis for the Prevention of Perinatal HIV and the Impact of Resistance Mutations on Subsequent Therapy

inferred← citeshttps://doi.org/10.2217/17469600.1.1.91openalex-snapshot

Development of Resistance After Administration of Single-Dose Nevirapine to Prevent Mother-To-Child Transmission of HIV

inferred← citeshttps://doi.org/10.2217/17469600.1.3.291openalex-snapshot

Strategies for the Optimal Sequencing of Antiretroviral Drugs Toward Overcoming and Preventing Drug Resistance

inferred← citeshttps://doi.org/10.2217/17584310.3.1.55openalex-snapshot

Minority Drug-Resistant HIV-1 Variants: Transmission and Response to Antiretroviral Therapy

inferred← citeshttps://doi.org/10.25646/5287openalex-snapshot

HIV-1 Resistenzentwicklung nach Einsatz antiretroviraler Medikamentenregime zur Prävention der Mutter-Kind-Übertragung von HIV in Uganda und Tansania

inferred← citeshttps://doi.org/10.3390/ijms12117861openalex-snapshot

Applications of Next-Generation Sequencing Technologies to Diagnostic Virology

inferred← citeshttps://doi.org/10.3390/v3040347openalex-snapshot

Clinical Management of HIV Drug Resistance

inferred← citeshttps://doi.org/10.3410/f.5558960.6693058openalex-snapshot

Faculty Opinions recommendation of Antiretroviral therapies in women after single-dose nevirapine exposure.

inferred← citeshttps://doi.org/10.3851/imp1687openalex-snapshot

HIV Type-1 Drug Resistance in Treatment-Naive Patients Monitored Using Minority Species Assays: A Systematic Review and Meta-Analysis

inferred← citeshttps://doi.org/10.3851/imp1698openalex-snapshot

Minor Drug-Resistant HIV Type-1 Variants in Breast Milk and Plasma of HIV Type-1-Infected Ugandan Women after Nevirapine Single-Dose Prophylaxis

inferred← citeshttps://doi.org/10.3851/imp1946openalex-snapshot

Short-Course Combivir after Single-Dose Nevirapine Reduces but Does Not Eliminate the Emergence of Nevirapine Resistance in Women

inferred← citeshttps://doi.org/10.3917/spub.086.0575openalex-snapshot

La prévention de la transmission du VIH de la mère à l'enfant : état des lieux au Bénin

inferred← citeshttps://doi.org/10.4103/0253-7184.192124openalex-snapshot

A study of antiretroviral resistance patterns in treatment experienced and naive human immunodeficiency virus infected-patients

inferred← citeshttps://doi.org/10.5451/unibas-005151671openalex-snapshot

Validation of replicative phenotyping to detect and assign HIV-1 resistance in clinical specimens

inferred← citeshttps://doi.org/10.5451/unibas-006196841openalex-snapshot

Molecular monitoring of HIV-1 drug resistance in Ifakara HIV-1 Cohort, Tanzania

inferred← citeshttps://doi.org/10.5772/1061openalex-snapshot

Antiviral Drugs - Aspects of Clinical Use and Recent Advances

inferred← citeshttps://doi.org/10.5772/33484openalex-snapshot

Use of Animal Models for Anti-HIV Drug Development

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.